Detalhe da pesquisa
1.
Impaired virus-specific T cell responses in patients with myeloproliferative neoplasms treated with ruxolitinib.
Hematol Oncol
; 38(4): 554-559, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32583904
2.
The Genetic Basis of Primary Myelofibrosis and Its Clinical Relevance.
Int J Mol Sci
; 21(23)2020 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33255170
3.
Autoantibodies against type I IFNs in patients with Ph-negative myeloproliferative neoplasms.
Blood
; 139(17): 2716-2720, 2022 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35100354
4.
Isolated congenital asplenia: An overlooked cause of thrombocytosis.
Am J Hematol
; 97(8): 1110-1115, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35266186
5.
Acquired von Willebrand syndrome in myeloproliferative neoplasms with extreme thrombocytosis.
Hematol Oncol
; 39(4): 589-592, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34320245
6.
Ruxolitinib treatment and risk of B-cell lymphomas in myeloproliferative neoplasms.
Am J Hematol
; 94(7): E185-E188, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30972817
7.
Facing erythrocytosis: Results of an international physician survey.
Am J Hematol
; 94(9): E225-E227, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31148218
8.
Haematological malignancies in relatives of patients affected with myeloproliferative neoplasms.
EJHaem
; 3(2): 475-479, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35846061
9.
SARS-CoV-2 vaccination and thrombotic risk in myeloproliferative neoplasms.
Res Pract Thromb Haemost
; 7(2): 100122, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36999122
10.
Systematic screening for SARS-CoV-2 in patients with hematological malignancies on active anticancer treatment in the outpatient setting.
Leuk Lymphoma
; 62(13): 3311-3312, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34261423
11.
Platelet count predicts driver mutations' co-occurrence in low JAK2 mutated essential thrombocythemia and myelofibrosis.
Leukemia
; 35(5): 1490-1493, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33051550
12.
Direct oral anticoagulants for myeloproliferative neoplasms: results from an international study on 442 patients.
Leukemia
; 35(10): 2989-2993, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34012132